参考文献/References:
[1] 王金泉,刘志红.急性时相反应及急性期蛋白[J].肾脏病与透析肾移植杂志,1999,8(6):552-555.
Wang JQ,Liu ZH.Acute-phase response and ARP[J].Chinese Journalof Nephrology Dialysis & Transplantation,1999,8(6):552-555.
[2] 张美雪.两种方法检测超敏C-反应蛋白的结果分析[J].医学检验与临床,2015,26(6):90-91.
Zhang MX.A study of two different detection methods of high sensitivity C-reactive protein[J].Medical Laboratory Science and Clinics,2015,26(6):90-91.
[3] 韩秀国,马宽生,夏 锋,等.肝硬化肝癌和无肝硬化肝癌患者围手术期肝衰竭和死亡的相关因素分析[J].中华消化外科杂志,2016,15(6):605-614.
Han XG,Ma KS,Xia F,et al.Prognostic factors resulting in the perioperative liver failure and death for the hepatocellular carcionma patients with or without cirrhosis[J].Chinese Journal of Digestive Surgery,2016,15(6):605-614.
[4] 马丽娜,刘晓彦,胡彦超,等.血清超敏C反应蛋白在慢性乙型肝炎进展中的意义[J].中华肝脏病杂志,2015,23(7):498-501.
Ma LN,Liu XY,Hu YC,et al.Clinical significance of high-sensitivity C-reactive protein in development of chronic hepatitis B[J].Chinese Journal of Hepatology,2015,23(7):498-501.
[5] 袁振兴,董 博,顾小红.慢性乙型肝炎患者HBV病毒载量与髓过氧化物酶检测分析[J].肝胆外科杂志,2015,23(4):292-293,310.
Yuan ZX,Dong B,Gu XH.Analysis between HBV-DNA vrial load,Myeloperoxidase in serum of chronic hepatitis B patients[J].Journal of Hepatobiliary Surgery,2015,23(4):292-293,310.
[6] 邓演超,李全双,沈红艳,等.自制HBV-DNA质控物的稳定性评价[J].现代检验医学杂志,2012,27(5):158-160.
Deng YC,Li QS,Shen HY,et al.Evaluation of the stability of self-made quality control substances of HBV-DNA[J].J Mod Lab Med,2012,27(5):158-160.
[7] Sato M,Ohkawa R,Yosimoto A,et al.Effects of se-rum amyloid A on thestructure and antioxidant ability of high-density lipoprotein[J].BioscienceReports,2016,36(4):369-387.
[8] Feingold KR,Grunfeld C.Effect of inflammation on HDL structure and function[J].Curr Opin Lipidol,2016,27(5):520-530.
[9] Piotti KC,Yantiss RK,Chen Z,et al.Serum amyloid A immunohistochemical staining patterns in hepatitis[J].Histopathology,2016,69(6):937-942.
[10] 钟 岚,张 一.超敏C反应蛋白在乙型肝炎中的临床应用价值[J].实验与检验医学,2012,30(4):342-344.
Zhong L,Zhang Y.The applied value of high sensitivity C reactionproteinin chronic hepatitis B patients[J].Experimental and Laboratory Medicine,2012,30(4):342-344.
[11] 张延青.肝癌患者血清淀粉样蛋白A和α1酸性糖蛋白检测的意义[J].基础医学论坛,2015,19(5):667-668.
Zhang YQ.The detection of meaning of SAA and α1-AG in liver cancer patients[J].The Medical Forum,2015,19(5):667-668.
[12] 赵绍林,吴惠毅,杨 晋,等.肝癌患者血清淀粉样蛋白A的表达及临床意义[J].中华实验外科杂志,2012,29(5):853.
Zhao SL,Wu HY,Yang J,et al.The expression and clinical significance ofserum amyloid A in liver cancer patients[J].Chinese Journal of ExperimentalSurgery,2012,29(5):853.
[13] 宋 琳,谭德明,方志雄.淀粉样蛋白A在治疗慢性丙型肝炎患者中的临床意义[J].中华临床感染病杂志,2008,1(2):96-98.
Song L,Tan DM,Fang ZX.Clinical significance of serum amyloid A proteinin patients with chronic hepatitis C virus infection[J].Chinese Journal of Clinical Infectious Diseases,2008,1(2):96-98.
相似文献/References:
[1]何涛君,吴正林,钟小强,等.乙肝患者HBV载量与IgA,IgG,IgM及C3,C4相关性研究[J].现代检验医学杂志,2015,30(04):67.[doi:10.3969/j.issn.1671-7414.2015.04.018]
HE Tao-jun,WU Zheng-lin,ZHONG Xiao-qiang,et al.Study on the Relationship between Patients with Hepatitis B
Viral Loads and Immunoglobulin A,G,M and Complement C3,C4[J].Journal of Modern Laboratory Medicine,2015,30(02):67.[doi:10.3969/j.issn.1671-7414.2015.04.018]
[2]褚小慧.慢性乙型肝炎患者血清HBV DNA,HBeAg和ALT滴度与恩替卡韦疗效的关系[J].现代检验医学杂志,2015,30(02):142.[doi:10.3969/j.issn.1671-7414.2015.02.045]
ZHU Xiao-hui.Relationship between the Level of HBV DNA,ALT and the Titers of
HBeAg with Effects of Entecavir in Chronic Hepatitis B Patients[J].Journal of Modern Laboratory Medicine,2015,30(02):142.[doi:10.3969/j.issn.1671-7414.2015.02.045]